Alloplex Biotherapeutics
  • For Investors
    • Our Approach
    • Opportunity
    • Efficacy
    • Evidence
    • SUPLEXA
    • Manufacturing
    • Strategic Focus
    • Strong IP
  • For Scientists / Clinicians
    • Pipeline
    • Publications
    • ENLIST Cells
    • SUPLEXA
    • Key Findings
    • Future Potential
    • Collaboration
  • For Patients
  • Newsroom
    • In the News
    • Releases and Updates
    • Media Resources
    • Media Contact
    • Publications
  • About
    • Our Story
    • Senior Leadership
    • Conferences
    • Shareholder
  • Contact
Alloplex Biotherapeutics
  • For Investors
    • Our Approach
    • Opportunity
    • Efficacy
    • Evidence
    • SUPLEXA
    • Manufacturing
    • Strategic Focus
    • Strong IP
  • For Scientists / Clinicians
    • Pipeline
    • Publications
    • ENLIST Cells
    • SUPLEXA
    • Key Findings
    • Future Potential
    • Collaboration
  • For Patients
  • Newsroom
    • In the News
    • Releases and Updates
    • Media Resources
    • Media Contact
    • Publications
  • About
    • Our Story
    • Senior Leadership
    • Conferences
    • Shareholder
  • Contact
  • For Investors
    • Our Approach
    • Opportunity
    • Efficacy
    • Evidence
    • SUPLEXA
    • Manufacturing
    • Strategic Focus
    • Strong IP
  • For Scientists / Clinicians
    • Pipeline
    • Publications
    • ENLIST Cells
    • SUPLEXA
    • Key Findings
    • Future Potential
    • Collaboration
  • For Patients
  • Newsroom
    • In the News
    • Releases and Updates
    • Media Resources
    • Media Contact
    • Publications
  • About
    • Our Story
    • Senior Leadership
    • Conferences
    • Shareholder
  • Contact
  • For Investors
    • Our Approach
    • Opportunity
    • Efficacy
    • Evidence
    • SUPLEXA
    • Manufacturing
    • Strategic Focus
    • Strong IP
  • For Scientists / Clinicians
    • Pipeline
    • Publications
    • ENLIST Cells
    • SUPLEXA
    • Key Findings
    • Future Potential
    • Collaboration
  • For Patients
  • Newsroom
    • In the News
    • Releases and Updates
    • Media Resources
    • Media Contact
    • Publications
  • About
    • Our Story
    • Senior Leadership
    • Conferences
    • Shareholder
  • Contact
Alloplex Logo    Follow Alloplex LinkedIn

USA

Head Office
300 Trade Center
Suite 6580
Woburn, MA
01801

AUSTRALIA

Level 5, 63 Pirie St
Adelaide, SA
5000

Stay up to date with Alloplex news, events and announcements.

Hidden

Alloplex Biotherapeutics ©2025 - Terms and conditions - Privacy policy